Efficacy of thrice-weekly long-acting insulin degludec provided by nurses in handicapped patients with type 2 diabetes on maintenace hemodialysis teratment
Phase 4
Recruiting
- Conditions
- type2 diabetes on hemodialysis treatment
- Registration Number
- JPRN-UMIN000038149
- Lead Sponsor
- Organization for Kidney and Metabolic Disease Ttreatment
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1. type 1 diabetes 2. self-injection is impossible
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method control of blood glucose status at 3 months after fixting insulin dosage
- Secondary Outcome Measures
Name Time Method